Carney. A Pilot Study of Negative Pressure Therapy with Autologous Skin Cell Suspensions in a Porcine Model. Presented at Northeast Region Burn Conference; 2020 November 6; Virtual. Desai. Aesthetic ...
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a ...
Please provide your email address to receive an email when new articles are posted on . The FDA has expanded its approval of the Recell system in combination with meshed autografting to include ...
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL ® Spray-On Skin™ Cells and improving operating room workflow ...
Credit: Avita Medical. The pediatric approval was based on data from the RECELL Compassionate Use (IDE 15945) and Continued Access (IDE 13053) studies. The Food and Drug Administration (FDA) has ...
VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today announced ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patientsFindings presented at the British Burn Association Annual Meeting support the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results